NFKB1 and metabolic dysfunction-associated steatohepatitis: Integrated analyses of transcriptional and non-transcriptional genes regulated by telmisartan identified cross-talk between the angiotensin-PPAR-NFκB signaling pathways, which could have contributed to the pharmacological effects of telmisartan on NASH.